Page 67 - Return Level Chart News Today

You might wish you owned these three stocks during the next bear market.

Author Bio Chris has covered Tech and Telecom companies for The Motley Fool since 2012. Follow him on Twitter for the latest tech stock coverage. Follow @tmfnewsie If you made a few New Years resolutions for 2021, Ive got some bad news for you -- nearly 80% of people abandon their resolutions by the second week of February. The good news is that if you set some investing goals for 2021 that youre considering ditching, its not too late to get back on track -- and we can ...

Author Bio Robin Hartill is a Florida-based personal finance writer and editor, and a CERTIFIED FINANCIAL PLANNER.™ She is a graduate of the University of Florida. The average 529 college savings plan is opened once the beneficiary has already celebrated their seventh birthday, according to Morningstar research. And thats actually a late start. A 529 plan gives you a limited number of mutual funds, often target-date funds, that are designed for an 18-year time horizon...

Author Bio Matthew is a senior energy and materials specialist with The Motley Fool. He graduated from Liberty University with a degree in Biblical Studies and a Masters of Business Administration. You can follow him on Twitter for the latest news and analysis of the energy and materials industries: Follow @matthewdilallo The global economy is in the midst of transitioning its power source from fossil fuels to renewable energy. It will take decades and trillions of doll...

Author Bio Daniel has been writing for Fool.com since 2019. A fan of value and dividend stocks, he covers the industrial sector, oil and gas, and renewable energy. He graduated summa cum laude from the University of Houston with a BBA in finance and marketing and a certificate in personal financial planning. The energy sector was the worst-performing sector in 2020. Now, its the best-performing sector so far in 2021. Chock-full of volatility and value traps -- yet ripe ...

Author Bio Daniel has been writing for Fool.com since 2019. A fan of value and dividend stocks, he covers the industrial sector, oil and gas, and renewable energy. He graduated summa cum laude from the University of Houston with a BBA in finance and marketing and a certificate in personal financial planning. Shares of midstream energy giant Kinder Morgan (NYSE:KMI) are quietly outperforming the market this year. The energy sector as a whole has gotten a lift from higher...

Author Bio Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Fool since April 2020. Lives in Québec City, Canada. Follow @Bio_Chameleon With a mouth-watering return of 1,770% in the past year, Novavax (NASDAQ:NVAX) is undoubtedly the best-performing coronavirus stock on the m...

Author Bio Daniel has been writing for Fool.com since 2019. A fan of value and dividend stocks, he covers the industrial sector, oil and gas, and renewable energy. He graduated summa cum laude from the University of Houston with a BBA in finance and marketing and a certificate in personal financial planning. In one week, shares of GameStop have gone from $35 to $350 as Reddit users bid up its stock price in an effort to crush hedge funds that were short the stock. A sim...

Author Bio Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Fool since April 2020. Lives in Québec City, Canada. Follow @Bio_Chameleon In the past 12 months, two of the best-performing biotech stocks were cancer immunotherapy firm Fate Therapeutics (NASDAQ:FATE) and German c...

Author Bio Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Fool since April 2020. Lives in Québec City, Canada. Follow @Bio_Chameleon Editas Medicine (NASDAQ:EDIT) is quickly becoming one of the hottest biotech and gene therapy stocks on the market. Over the past year, it ha...